Product Information
TROPICAMIDE 1% EYE DROPS is a generic product labeled by Somerset Therapeutics, LLC, priced at $0.5515 per ML under NDC 70069012101. Its NADAC has been published 263 times since Feb 26, 2020.
FDA first approved this application on Dec 12, 2019. Its Orange Book therapeutic-equivalence code is AT.
Strength
10 mg/mL
Manufacturer
Somerset Therapeutics, LLCNDC
70069012101
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TROPICAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207524FDA Approved
12/12/2019
TE Code
AT
On Market Since
12/12/2019
Pharmacological Classes
Price Statistics
The NADAC for TROPICAMIDE 1% EYE DROPS has been published 263 times since Feb 26, 2020, and over the history we have for it it has risen 9.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5515 per ML |
|---|---|
| All-time high | $0.5515 (Sep 30, 2026) |
| All-time low | $0.4203 (Sep 18, 2024) |
| 52-week high | $0.5515 |
| 52-week low | $0.4784 |
| Median price | $0.4824 |
| Average price | $0.4673 |
| Largest weekly change | -14.9% (May 18, 2022) |
| Weeks tracked | 263 |
| Tracking since | Feb 26, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Somerset Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tropicamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TROPICAMIDE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for TROPICAMIDE 1% EYE DROPS, manufactured by Somerset Therapeutics, LLC, is $0.5515 per ML (NDC 70069012101), effective Sep 30, 2026.
How has the price of TROPICAMIDE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for TROPICAMIDE 1% EYE DROPS has risen 9.2%. It has been tracked across 263 weekly CMS publications since Feb 26, 2020.
What are the highest and lowest recorded NADAC prices for TROPICAMIDE 1% EYE DROPS?
Since Feb 26, 2020, the NADAC for TROPICAMIDE 1% EYE DROPS has ranged from a low of $0.4203 (Sep 18, 2024) to a high of $0.5515 (Sep 30, 2026), with a median of $0.4824 per ML.
Are there cheaper alternatives to TROPICAMIDE 1% EYE DROPS?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TROPICAMIDE 1% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures TROPICAMIDE 1% EYE DROPS?
TROPICAMIDE 1% EYE DROPS (NDC 70069012101) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.